Emami R&D per Employee
R&D Spending per Employee of Emami (EMAMILTD.NS) as of Jul 16, 2026.
Get this data via API
Financial Data API
R&D per Employee
0.00INR
Last updated:
R&D Spending per Employee of Emami is 2026 0.00 INR. R&D Spending per Employee of Emami was 2025 0.00 INR. It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API
Emami Stock analysis
What does Emami do? Emami Ltd is an Indian company that was founded in 1974 by R.S. Agarwal and R.S. Goenka. It is headquartered in Kolkata and operates in the FMCG (Fast-Moving Consumer Goods) sector. The company operates in various sectors including healthcare, beauty care, personal care, and paper manufacturing.
Emami's business model is to produce high-quality and affordable products. They focus on strong brand building and distribution in the Indian market. The company offers both standard products and specialized products for specific target groups. Emami has been recognized for its innovative products and commitment to sustainability.
One of Emami's leading departments is the healthcare department. They produce various pharmaceuticals and dietary supplements for various diseases and ailments including diabetes, hypertension, obesity, and gastrointestinal problems. The company also offers homeopathic products and works closely with doctors and healthcare organizations.
Another important area of Emami is the beauty and personal care department, which offers various products such as creams, lotions, oils, and soaps. Emami's most well-known brands are Fair and Handsome, a skincare brand for men, and Boroplus, a brand for personal care products. The company also has a product line specifically for women called Emami 7 Oils in One, which combines 7 different oils that are beneficial for women's skin and hair health.
Emami also has a paper manufacturing department called Emami Paper Mills Ltd. The company produces various types of paper products including writing paper, glossy paper, coated paper, and packaging materials. They also have a strong presence in the export business and deliver their products to various countries.
Emami is a rapidly growing company that has also expanded internationally in recent years. The company has opened offices in various countries such as Bangladesh, Indonesia, and Russia. They also have a strong online presence and distribute their products through various e-commerce platforms.
Overall, Emami is a versatile company with a wide portfolio of products and services. The company has firmly established itself in the Indian market and is expected to continue to grow and expand. With its dedication to quality and sustainability and its innovative products, Emami will play an important role in the FMCG industry in the future. Emami is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Emami stock
On Eulerpool you can find the complete historical development of R&D Spending per Employee Emami since 2006 – with annual values, charts, and detailed analysis.
Access this data via the Eulerpool API
Workforce — Emami
All Key Metrics — Emami
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth